Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

• Status: Recruiting
• Trial end date: 2022-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Anna Rockich
• Treatments: Ketamine

Criteria

Inclusion Criteria:

• willing to give informed consent

• scheduled for elective thoracic aorta repair or thoracoabdominal aortic repair

• requires naloxone continuous infusion for spinal prophylaxis

Exclusion Criteria:

• allergy to ketamine, acetaminophen, or fentanyl

• diagnosis of schizophrenia

• history of hydrocephalus or central nervous system mass

• incarcerated individuals

• pregnant or lactating individuals